Insignificant disease among men with intermediate-risk prostate cancer

被引：0
|
作者：
Sung Kyu Hong
Emily Vertosick
Daniel D. Sjoberg
Peter T. Scardino
James A. Eastham
机构：
[1] Memorial Sloan-Kettering Cancer Center,Urology Service, Department of Surgery
[2] Seoul National University Bundang Hospital,Department of Urology
[3] Memorial Sloan-Kettering Cancer Center,Department of Epidemiology and Biostatistics
[4] Cornell University,Department of Urology, Weill Cornell Medical College
来源：
World Journal of Urology | 2014年 / 32卷
关键词：
Prostate; Prostatic neoplasms; Insignificant; Intermediate risk; Prediction;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1417 / 1421
页数：4
相关论文
共 50 条
  • [41] Validation of the Contemporary Epstein Criteria for Insignificant Prostate Cancer in European Men
    Jeldres, Claudio
    Suardi, Nazareno
    Walz, Jochen
    Hutterer, Georg C.
    Ahyai, Sascha
    Lattouf, Jean-Baptiste
    Haese, Alexander
    Graefen, Markus
    Erbersdobler, Andreas
    Heinzer, Hans
    Huland, Hartwig
    Karakiewicz, Pierre I.
    EUROPEAN UROLOGY, 2008, 54 (06) : 1306 - 1313
  • [42] Prostate-specific antigen density predicts favorable pathology and biochemical recurrence in patients with intermediate-risk prostate cancer
    Kang, Ho Won
    Do Jung, Hae
    Lee, Joo Yong
    Kwon, Jong Kyou
    Jeh, Seong Uk
    Cho, Kang Su
    Ham, Won Sik
    Choi, Young Deuk
    ASIAN JOURNAL OF ANDROLOGY, 2016, 18 (03) : 480 - 484
  • [43] The Clinical Utility of the Genomic Prostate Score in Men with Very Low to Intermediate Risk Prostate Cancer
    Gaffney, Christopher
    Golan, Ron
    Cantu, Miguel D.
    Scognamiglio, Theresa
    McCarthy, Hiral
    Mosquera, Juan Miguel
    McClure, Timothy D.
    Barbieri, Christopher E.
    Robinson, Brian D.
    Khani, Francesca
    JOURNAL OF UROLOGY, 2019, 202 (01): : 96 - 101
  • [44] Intravaginal brachytherapy alone for intermediate-risk endometrial cancer
    Alektiar, KM
    Venkatraman, E
    Chi, DS
    Barakat, RR
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2005, 62 (01): : 111 - 117
  • [45] Role of combined radiation and androgen deprivation therapy in intermediate-risk prostate cancer Statement from the DEGRO working group on prostate cancer
    Beck, Marcus
    Boehmer, Dirk
    Aebersold, Daniel M.
    Albrecht, Clemens
    Flentje, Michael
    Ganswindt, Ute
    Hoecht, Stefan
    Hoelscher, Tobias
    Mueller, Arndt-Christian
    Niehoff, Peter
    Pinkawa, Michael
    Sedlmayer, Felix
    Zips, Daniel
    Zschaeck, Sebastian
    Budach, Volker
    Wiegel, Thomas
    Ghadjar, Pirus
    STRAHLENTHERAPIE UND ONKOLOGIE, 2020, 196 (02) : 109 - 116
  • [46] Androgen deprivation therapy and radiotherapy in intermediate-risk prostate cancer: A systematic review and meta-analysis
    Chen, Jiuzhou
    Yuan, Yan
    Fang, Miao
    Zhu, Youqi
    Sun, Xueqing
    Lou, Yufei
    Xin, Yong
    Zhou, Fengjuan
    FRONTIERS IN ENDOCRINOLOGY, 2023, 13
  • [47] Combination external beam radiation and brachytherapy boost with androgen deprivation for treatment of intermediate-risk prostate cancer
    Hurwitz, Mark D.
    Halabi, Susan
    Archer, Laura
    McGinnis, Lamar S.
    Kuettel, Michael R.
    DiBiase, Steven J.
    Small, Eric J.
    CANCER, 2011, 117 (24) : 5579 - 5588
  • [48] The value of endorectal MR imaging to predict positive biopsies in clinically intermediate-risk prostate cancer patients
    Vilanova, JC
    Comet, J
    Capdevila, A
    Barceló, J
    Dolz, JL
    Huguet, M
    Barceló, C
    Aldomà, J
    Delgado, E
    EUROPEAN RADIOLOGY, 2001, 11 (02) : 229 - 235
  • [49] Biopsy Assessment of Oncologic Control 3 Years Following Primary Partial Gland Cryoablation: A Prospective Cohort Study of Men With Intermediate-risk Prostate Cancer
    Wysock, James S.
    Rapoport, Eli
    Hernandez, Hunter
    Gogaj, Rozalba
    Lepor, Herbert
    JOURNAL OF UROLOGY, 2023, 210 (03): : 454 - 464
  • [50] The clinical significance of persistent cancer cells on prostate biopsy after high-dose-rate brachytherapy boost for intermediate-risk prostate cancer
    D'Alimonte, Laura
    Helou, Joelle
    Sherman, Christopher
    Loblaw, Andrew
    Chung, Hans T.
    Ravi, Ananth
    Deabreu, Andrea
    Zhang, Liying
    Morton, Gerard
    BRACHYTHERAPY, 2015, 14 (03) : 309 - 314
12345